Laboratory diagnosis of Haemophilia and von-willebrand disease

 Laboratory diagnosis of Haemophilia and von-willebrand disease

Hemophilia is a bleeding disorder in which an individual’s blood does not clot properly. It arises due to problems or deficiencies with blood clotting proteins. Researchers estimate that around 1 in every 10,000 peopleTrusted Source are born with hemophilia.

The main diagnostic lab tests are clotting activity tests. Other tests can help diagnose hemophilia by ruling out other conditions or indicating that someone has an elevated risk of hemophilia.

This article describes the main lab tests for hemophilia. It also discusses other hemophilia lab tests and explains how much they may cost.

Blood tests

The only way to definitively diagnose hemophilia is through blood tests to confirm low levels of clotting factors.

Blood tests to diagnose hemophilia can be divided into two broad categories:

  • screening tests, which are general assessments of blood health and clotting ability
  • clotting factor tests, which specifically measure the activity of the clotting factors that are missing in specific types of hemophilia.

Screening tests can help rule out other conditions that affect blood clotting, while clotting factor tests can help definitively diagnose hemophilia and pinpoint its type and severity.

Screening tests

Screening tests are general assessments of blood health and clotting ability. While they can’t be used to definitively diagnose hemophilia, they can be useful for confirming that a patient has a blood clotting disorder and for ruling out nonhemophilia conditions that can cause similar clotting issues.

Complete blood count (CBC)

A complete blood count, or CBC, is a standard test that measures the size and number of oxygen-carrying red blood cells in the bloodstream. A CBC also assesses the amount of hemoglobin, the oxygen-carrying protein inside red blood cells, as well as the number of infection-fighting white blood cells and platelets, which are cell fragments that play a key role in blood clotting.

People with hemophilia usually have normal results on a CBC test, though patients who have recently had heavy or prolonged bleeding may have low red blood cell counts and hemoglobin levels, called anemia. Low platelet counts can cause abnormal bleeding similar to that seen in hemophilia. Thus, a CBC can help rule out low platelet counts as a possible cause for unusual bleeding.

Activated partial thromboplastin time (APTT) test

The activated partial thromboplastin time (APTT) test assesses how well certain clotting proteins — specifically FVIII, FIX, FXI, and FXII — are working by measuring how long it takes for a clot to form in a blood sample. The test can be done in a doctor’s office and results usually are available the same day.

The clotting factors assessed in the test include all the proteins whose deficiency can cause hemophilia A, B, and C. As such, people with any of these hemophilia types will tend to have abnormal APTT results, with blood taking longer than normal to clot.

While abnormal results on an APTT test are indicative of hemophilia, because it measures the activity of several different clotting factors simultaneously, the test can’t be used to determine the type of hemophilia a patient has.

People with milder forms of hemophilia may also have normal APTT results, so a normal result on this test also doesn’t guarantee a person doesn’t have hemophilia.

Prothrombin time test (PTT) test

Like the APTT test, the PTT test measures the activity of several clotting proteins, specifically FI, FII, FV, FVII, and FX. People with the most common types of hemophilia have normal levels of all these clotting factors, so PTT test results are typically normal. The test can help rule out other clotting disorders.

Fibrinogen test

Fibrinogen is another name for FI. This test measures the amount of fibrinogen in the blood and/or how well this protein is helping to form clots. Since fibrinogen is not missing in any type of hemophilia, people with the condition will usually have normal results on this test.

Clotting factor tests

Clotting factor tests, also known as factor assays, measure the activity of clotting factor proteins in the blood. Since the different types of hemophilia are caused by deficiencies in specific clotting factors, these tests are the main method to definitively diagnose hemophilia and determine its exact type.

Results from clotting factor tests are usually given as a percentage of normal activity. Theoretically, a person without hemophilia would have about 100% normal activity — though clotting factor activity can vary naturally from person to person, and activities anywhere between 50% and 150% are generally considered within the normal range.

Hemophilia is generally diagnosed when clotting factor activity is less than 40% of normal. Its severity is determined based on the specific activity level. For example:

  • in mild hemophilia, clotting factor activity is higher than 5%, but less than 40%
  • in moderate hemophilia, clotting factor activity ranges from 1% to 5%
  • in severe hemophilia, clotting factor activity is lower than 1%.

Determining the specific type and severity of hemophilia is important for creating an individualized treatment plan.

Hemophilia diagnosis infographic

Signs to get tested

About 30% of people with hemophilia have no family history of the disease. These patients usually are only diagnosed after they show specific signs that prompt testing. Such signs may include:

  • bleeding without a clear cause (spontaneous bleeding)
  • prolonged bleeding following an injury or a medical procedure that punctures the skin, such as circumcision, vaccination, or surgery
  • excessive bruising or raised bruises
  • bleeding in the head of newborns following a difficult birth, especially if assistive devices like a vacuum or forceps were used during delivery.

People with severe hemophilia usually have early signs of bleed-related problems in the first few months of life, so most cases of severe hemophilia are diagnosed while patients are still infants.

In cases of moderate or mild hemophilia, signs of excessive bleeding might not become apparent until later in childhood, adolescence, or even adulthood. A common sign of hemophilia in people who aren’t diagnosed as infants is excessive bruising as the child starts to crawl and walk.





https://www.cdc.gov/ncbddd/hemophilia/diagnosis.html#:~:text=Diagnosis%20includes%20screening%20tests%20and,of%20hemophilia%20and%20the%20severity.

https://hemophilianewstoday.com/diagnosis-of-hemophilia?cn-reloaded=1

https://www.medicalnewstoday.com/articles/hemophilia-labs#prothrombin-time-test

https://arupconsult.com/content/hemophilia

https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2516.1995.tb00060.x

https://www.haemophilia.org.au/bleeding-disorders/haemophilia/haemophilia-diagnosis/

.

.

.

.

Comments

Popular posts from this blog

Applied Hematology–II (BMLS 601-18)

HISTOTECHNOLOGY – II & Cytology BMLS 605-18

BMLS 501-18 Applied Hematology-I NOTES